SAFE-BioPharma Receives Safe Harbor Certification

FT. LEE, N.J.--(Business Wire)--
SAFE-BioPharma Association has certified compliance with the US Department of
Commerce and European Union Safe Harbor requirements for the protection of
personal data. The non-profit association developed and manages the global
SAFE-BioPharma digital identity and signature standard, used within the
biopharmaceutical and healthcare industries.

To qualify, SAFE-BioPharma developed its privacy policy to comply with the
E.U.`s Safe Harbor Principles. Safe Harbor Certification will enable
SAFE-BioPharma to transfer personal data outside the E.U., expediting the flow
of information between European clients and the United States. The certification
recognizes that SAFE-BioPharma`s privacy and data security policies provide
"adequate protection" for personal data from its European clients as required by
the European Union's Data Protection Directive.

"Receiving Safe Harbor status assures SAFE-BioPharma member companies that use
of the standard to manage digital identities and/or to apply digital signatures
is consistent with E.U. regulations regarding data transfer and will further
enhance our capabilities to better serve our European clients," said Mollie
Shields-Uehling, President and CEO, SAFE-BioPharma Association.

Details regarding E.U. Safe Harbor Principles are available at
http://www.safe-biopharma.org/infocenter/SafeHarborOverview.pdf.

About SAFE-BioPharma Association (www.safe-biopharma.org) SAFE-BioPharma
Association is the non-profit association that created and manages the
SAFE-BioPharma digital identity and signature standard for the pharmaceutical
and healthcare industries.

The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and
other business risk associated with business-to-business and
business-to-regulator electronic transactions. It facilitates interoperability
by providing a secure, enforceable, and regulatory-compliant way to verify
identities of parties involved in electronic transactions. Because the standard
is linked to the Federal Bridge PKI Architecture through the 4BF
(http://www.the4bf.com), a SAFE-BioPharma digital identity can be trusted by any
Federal agency. SAFE-BioPharma`s vision is to be a catalyst in transforming the
biopharmaceutical and healthcare communities to a fully electronic business
environment by 2012.

The Association`s members include:

* Abbott (NYSE:ABT)
* Amgen (NASDAQ:AMGN)
* AstraZeneca (NYSE:AZN)
* Bristol-Myers Squibb (NYSE:BMY)
* GlaxoSmithKline (NYSE:GSK)
* Johnson & Johnson (NYSE:JNJ)
* Eli Lilly (NYSE:LLY)
* McDougall Scientific
* Merck (NYSE:MRK)
* National Notary Association
* Novartis
* Pfizer (NYSE:PFE)
* Premier Inc.
* Roche
* Sanofi-Aventis (NYSE:SNY).
* ScheringPlough-Organon (NYSE:SGP)
* SNAP Diagnostics

SAFE-BioPharma is a trademark of SAFE-BioPharma Association. Any use of this
trademark requires approval from SAFE-BioPharma Association.

SAFE-BioPharma Association
Jon Weisberg
M 801-860-9977
O 801-359-9977
Jon.weisberg@safe-biopharma.org

Copyright Business Wire 2009